Agenda Details

Learn more about sessions and presentations at the 26th Annual Meeting

Detailed Program

In vitro pharmacology study of gene therapy using retina organoids of CLN2 patient-derived induced pluripotent stem cells

Kwi Hye Kim, PhD. REGENXBIO Inc, Rockville, MD

Disclosures: K. Kim: None.

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.